Reversible Contraceptive Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

Reversible Contraceptive Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

Summary

Reversible Contraceptive Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Reproductive Health Devices therapeutic area.

Reversible Contraceptive Devices are used as birth control to prevent unwanted pregnancy. Reversible Contraceptive Devices are inserted or implanted into women of child-bearing age, often for long periods of time.

Reversible Contraceptives that remain in use for many years are considered to be long-acting and are the most popular class of reversible contraceptive devices. This is in contrast to devices such as diaphragms that must be inserted and removed before and after intercourse. IUDs are further classified in two types, copper IUDs and Hormonal IUDs. While other forms of modern contraceptives are used (including hormone injections, oral pills, and condoms). Modern contraceptives are widely used in the developed world, while usage rates tend to be lower in developing economies. IUDs are the most common type of reversible contraceptive device. Modern contraceptives are widely used in the developed world, while usage rates tend to be lower in developing economies. The prevalence of modern contraceptives is expected to increase across each geographic region throughout the forecast period.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Reversible Contraceptive Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Reversible Contraceptive Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Reversible Contraceptive Devices market.
• Competitive dynamics insights and trends provided for Reversible Contraceptive Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Allergan Aesthetics, Bayer AG, CooperSurgical Inc, Organon, Meril Life Sciences Pvt Ltd, Pregna International Ltd, Shanghai Dahua Pharmaceuticals Co Ltd, HLL Lifecare Ltd, Kessel Marketing & Vertriebs GmbH, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Reversible Contraceptive Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Reversible Contraceptive Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Reversible Contraceptive Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Reversible Contraceptive Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Please note: this is delivered as an Excel file.